Search Results - "Maugeais, C"

GET: A generic electronics system for TPCs and nuclear physics instrumentation by Pollacco, E.C., Grinyer, G.F., Abu-Nimeh, F., Ahn, T., Anvar, S., Arokiaraj, A., Ayyad, Y., Baba, H., Babo, M., Baron, P., Bazin, D., Beceiro-Novo, S., Belkhiria, C., Blaizot, M., Blank, B., Bradt, J., Cardella, G., Carpenter, L., Ceruti, S., De Filippo, E., Delagnes, E., De Luca, S., De Witte, H., Druillole, F., Duclos, B., Favela, F., Fritsch, A., Giovinazzo, J., Gueye, C., Isobe, T., Hellmuth, P., Huss, C., Lachacinski, B., Laffoley, A.T., Lebertre, G., Legeard, L., Lynch, W.G., Marchi, T., Martina, L., Maugeais, C., Mittig, W., Nalpas, L., Pagano, E.V., Pancin, J., Poleshchuk, O., Pedroza, J.L., Pibernat, J., Primault, S., Raabe, R., Raine, B., Rebii, A., Renaud, M., Roger, T., Roussel-Chomaz, P., Russotto, P., Saccà, G., Saillant, F., Sizun, P., Suzuki, D., Swartz, J.A., Tizon, A., Trifiró, A., Usher, N., Wittwer, G., Yang, J.C.

“…General Electronics for TPCs (GET) is a generic, reconfigurable and comprehensive electronics and data-acquisition system for nuclear physics instrumentation…”
Get full text

AGATA DAQ-box: a unified data acquisition system for different experimental conditions by Korichi, A., Clément, E., Dosme, N., Legay, E., Stézowski, O., Goasduff, A., Aubert, Y., Dudouet, J., Elloumi, S., Gauron, P., Grave, X., Gulmini, M., Jacob, J., Lafage, V., Jeannic, P. Le, Lalaire, G., Ljungvall, J., Maugeais, C., Michelagnoli, C., Molini, R., Philippon, G., Pietri, S., Ralet, D., Roetta, M., Saillant, F., Taurigna-Quere, M., Toniolo, N.

“…The AGATA tracking detector array represents a significant improvement over previous Compton suppressed arrays. The construction of AGATA led to numerous…”
Get full text

Demonstrator Detection System for the Active Target and Time Projection Chamber (ACTAR TPC) project by Roger, T., Pancin, J., Grinyer, G.F., Mauss, B., Laffoley, A.T., Rosier, P., Alvarez-Pol, H., Babo, M., Blank, B., Caamaño, M., Ceruti, S., Daemen, J., Damoy, S., Duclos, B., Fernández-Domínguez, B., Flavigny, F., Giovinazzo, J., Goigoux, T., Henares, J.L., Konczykowski, P., Marchi, T., Lebertre, G., Lecesne, N., Legeard, L., Maugeais, C., Minier, G., Osmond, B., Pedroza, J.L., Pibernat, J., Poleshchuk, O., Pollacco, E.C., Raabe, R., Raine, B., Renzi, F., Saillant, F., Sénécal, P., Sizun, P., Suzuki, D., Swartz, J.A., Wouters, C., Wittwer, G., Yang, J.C.

“…The design, realization and operation of a prototype or “demonstrator” version of an active target and time projection chamber (ACTAR TPC) for experiments in…”
Get full text

Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone by Ristic, S., Collober-Maugeais, C., Pecher, E., Cressier, F.

“…Aims To compare the effects of nateglinide plus metformin with gliclazide plus metformin on glycaemic control in patients with Type 2 diabetes. Methods…”
Get full text

The thienotriazolodiazepine Ro 11‐1464 increases plasma apoA‐I and promotes reverse cholesterol transport in human apoA‐I transgenic mice by Zanotti, I, Maugeais, C, Pedrelli, M, Gomaraschi, M, Salgam, P, Calabresi, L, Bernini, F, Kempen, H

“…BACKGROUND AND PURPOSE Ro 11‐1464 is a thienotriazolodiazepine previously described to selectively stimulate apolipoprotein A‐I (apoA‐I) production and mRNA…”
Get full text

Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results by Ristic, S., Collober-Maugeais, C., Cressier, F., Tang, P., Pecher, E.

“…Aim:  To compare long‐term efficacy and safety of nateglinide plus metformin with those of gliclazide plus metformin in patients with type 2 diabetes not…”
Get full text

Musett: A segmented Si array for Recoil-Decay-Tagging studies at VAMOS by Theisen, Ch, Jeanneau, F., Sulignano, B., Druillole, F., Ljungvall, J., Paul, B., Virique, E., Baron, P., Bervas, H., Clément, E., Delagnes, E., Dijon, A., Dossat, E., Drouart, A., Farget, F., Flouzat, Ch, De France, G., Görgen, A., Houarner, Ch, Jacquot, B., Korten, W., Lebertre, G., Lecornu, B., Legeard, L., Lermitage, A., Lhenoret, S., Marry, C., Maugeais, C., Menager, L., Meunier, O., Navin, A., Nizery, F., Obertelli, A., Rauly, E., Raine, B., Rejmund, M., Ropert, J., Saillant, F., Savajols, H., Schmitt, Ch, Tripon, M., Wanlin, E., Wittwer, G.

“…A new segmented silicon-array called MUSETT has been built for the study of heavy elements using the Recoil-Decay-Tagging technique. MUSETT is located at the…”
Get full text

Analysis of “On/Off” Kinetics of a CETP Inhibitor Using a Mechanistic Model of Lipoprotein Metabolism and Kinetics by Lu, J, Cleary, Y, Maugeais, C, Kiu Weber, CI, Mazer, NA

“…RG7232 is a potent inhibitor of cholesteryl‐ester transfer protein (CETP). Daily oral administration of RG7232 produces a dose‐ and time‐dependent increase in…”
Get full text

Effect of n-3 fatty acids on metabolism of apoB100-containing lipoprotein in type 2 diabetic subjects by Ouguerram, K., Maugeais, C., Gardette, J., Magot, T., Krempf, M.

“…The effect of long-chain n-3 PUFA on the metabolism of apoB100-containing lipoprotein in diabetic subjects is not fully understood. The objective of the…”
Get full text

Inhibition of cholesteryl ester transfer protein (CETP): Different in vitro characteristics of RO4607381/JTT-705 and torcetrapib (TOR) by Niesor, E.J, von der Marck, E, Brousse, M, Maugeais, C

Get full text

High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study by Frénais, R, Ouguerram, K, Maugeais, C, Mahot, P, Maugère, P, Krempf, M, Magot, T

“…High density lipoprotein (HDL) kinetics were studied by infusing [5,5,5-2H3]-leucine in five subjects with normal glucose tolerance and eight patients with…”
Get full text

In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism : A kinetic study in control subjects and patients with type II diabetes mellitus by FRENAIS, R, NAZIH, H, OUGUERRAM, K, MAUGEAIS, C, ZAÏR, Y, BARD, J. M, CHARBONNEL, B, MAGOT, T, KREMPF, M

“…The aim of this study was to delineate the role of lipoprotein lipase (LPL) activity in the kinetic alterations of high density lipoprotein (HDL) metabolism in…”
Get full text

A new labeling approach using stable isotopes to study in vivo plasma cholesterol metabolism in humans by Ouguerram, K., Krempf, M., Maugeais, C., Maug[egrave]re, P., Darmaun, D., Magot, T.

“…A method to study reverse cholesterol transport in humans was developed using stable isotopes and kinetic analysis. Three normolipidemic subjects received…”
Get full text

Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study by Frénais, R, Ouguerram, K, Maugeais, C, Marchini, J S, Benlian, P, Bard, J M, Magot, T, Krempf, M

“…Heterozygous familial hypercholesterolemia (FH) is associated with a moderate decrease of plasma apoA-I and HDL-cholesterol levels. The aim of the study was to…”
Get full text

Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus by Frénais, R, Ouguerram, K, Maugeais, C, Mahot, P, Charbonnel, B, Magot, T, Krempf, M

“…The effect of a dietary fish oil supplementation on metabolism of HDL was studied in type II diabetes mellitus. Endogenous labeling of HDL-apo AI was performed…”
Get full text

High-density lipoprotein metabolism: molecular targets for new therapies for atherosclerosis by Kawashiri, M A, Maugeais, C, Rader, D J

“…New therapeutic approaches to the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD) are needed. Plasma levels of high-density…”
Get full text

Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia by MAUGEAIS, Cyrille, OUGUERRAM, Khadija, FRENAIS, Regis, MAUGERE, Pascale, CHARBONNEL, Bernard, MAGOT, Thierry, KREMPF, Michel

“…The acute reduction of low-density lipoprotein (LDL) cholesterol obtained by LDL-apheresis allows the role of the high level of circulating LDL on lipoprotein…”
Get full text

Lipoprotein Kinetics in Patients With Analbuminemia: Evidence for the Role of Serum Albumin in Controlling Lipoprotein Metabolism by Maugeais, C, Braschi, S, Ouguerram, K, Maugeais, P, Mahot, P, Jacotot, B, Darmaun, D, Magot, T, Krempf, M

“…In vitro data suggested that albumin is a key factor controlling apolipoprotein (apo) synthesis by hepatocytes. Studies in analbuminemic rats have shown an…”
Get full text

Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia by Fr[eacute]nais, R., Maugeais, C., Ouguerram, K., Za[iuml ]r, Y., Bard, J.M., Charbonnel, B., Magot, T., Krempf, M.

“…In patients with heterozygous familial hypercholesterolemia (FH), both synthetic and clearance rates of high-density lipoproteins (HDL) are increased compared…”
Get full text

A minimal model using stable isotopes to study the metabolism of apolipoprotein B-containing lipoproteins in humans by Maugeais, C, Ouguerram, K, Krempf, M, Maugeais, P, Gardette, J, Bigot, E, Magot, T

“…A protocol using stable isotopes, developed to measure apolipoprotein B turnover in humans, was tested by intravenous infusion of [2H3]-leucine into 5…”
Get more information